prolame has been researched along with No-Reflow Phenomenon in 1 studies
*No-Reflow Phenomenon: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coral-Vázquez, RM; de la Peña, A; De Los Santos, S; Fernández-G, JM; Flores, M; Flores, PL; Hernández-Reséndiz, S; Palma-Flores, C; Román-Anguiano, NG; Zazueta, C | 1 |
1 other study(ies) available for prolame and No-Reflow Phenomenon
Article | Year |
---|---|
Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade.
Topics: Animals; Blotting, Western; Disease Models, Animal; Endothelial Cells; Estrenes; Hemodynamics; Humans; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; No-Reflow Phenomenon; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Umbilical Veins | 2015 |